Spineology Inc

Spineology Inc manufactures expandable interbody fusion implants for minimally invasive and ultra-minimally invasive lumbar spine surgery. The company's flagship product line, OptiMesh, comprises conformable, patient-specific expandable interbody devices designed to adapt to individual endplate morphology while delivering through minimal surgical portals. OptiMesh variants support multiple surgical approaches: open TLIF/PLIF, minimally invasive TLIF, and ultra-minimally invasive techniques (OptiLIF and OptiLIF Endo for endoscopic fusion). Recent product launches include OptiMesh Align, which offers up to 20° lordotic range with independent anterior and posterior expansion control, and OptiMesh HA Nano, featuring a nano-thin hydroxyapatite surface treatment designed to promote osseointegration and reduce infection risk. The company's SCOUT IDE (Investigational Device Exemption) trial demonstrated 98% fusion rate at 12 months, 92% patient satisfaction (excellent/good), and clinically meaningful reductions in back pain and disability scores. Spineology reports over 50,000 implants placed and 20+ clinical publications backing product performance. Products incorporate biologics delivery capability and are used in open and percutaneous approaches for lumbar degenerative disc disease, providing disc height restoration, alignment correction, and biomechanical stability. The company serves spine surgeons and neurosurgeons in hospital and surgical center settings across the United States.